Outset Medical (OM) Non-Current Deffered Revenue (2019 - 2026)
Outset Medical's (OM) quarterly Non-Current Deffered Revenue came in at $366000.0 in Q1 2026, down 54.48% year-on-year from $804000.0 in Q1 2025, and down 9.85% on a QoQ basis from $406000.0 in Q4 2025.
Outset Medical (OM) Non-Current Deffered Revenue (2019 - 2026) Analysis & Trends
Outset Medical (OM) has 8 years of Non-Current Deffered Revenue data on file, last reported at $366000.0 in Q1 2026.
- On a quarterly basis, Non-Current Deffered Revenue fell 54.48% year-over-year to $366000.0 in Q1 2026; TTM through Mar 2026 was $366000.0, a 54.48% decrease from a year earlier, with the FY2025 full-year figure at $406000.0, down 51.9% from the prior year.
- Non-Current Deffered Revenue for Q1 2026 stood at $366000.0, down from $406000.0 in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for OM reached as high as $844000.0 in Q4 2024 and fell as low as $77000.0 in Q3 2024.
- Historically, Non-Current Deffered Revenue has averaged $304294.1 across 5 years, with a median of $186000.0 in 2024.
- Across the five-year window, Non-Current Deffered Revenue sank 63.81% in 2022 and soared 777.92% in 2025, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $151000.0 in 2022, then tumbled by 33.11% to $101000.0 in 2023, then surged by 735.64% to $844000.0 in 2024, then sank by 51.9% to $406000.0 in 2025, then dropped by 9.85% to $366000.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $366000.0 in Q1 2026, $406000.0 in Q4 2025, and $676000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.71 Bn | 99.49 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.59 Bn | 44.92 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.40 Bn | 27.29 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.37 Bn | 2.07 Bn | 512.79 Mn |
| 10 | Outset Medical | 79,738.82 | -286.56 Mn | 12.10 Mn | 366,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 366,000.00 |
| Dec 31, 2025 | 406,000.00 |
| Sep 30, 2025 | 676,000.00 |
| Jun 30, 2025 | 587,000.00 |
| Mar 31, 2025 | 804,000.00 |
| Dec 31, 2024 | 844,000.00 |
| Sep 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 130,000.00 |
| Mar 31, 2024 | 186,000.00 |
| Dec 31, 2023 | 101,000.00 |
| Sep 30, 2023 | 99,000.00 |
| Jun 30, 2023 | 89,000.00 |
| Mar 31, 2023 | 116,000.00 |
| Dec 31, 2022 | 151,000.00 |
| Sep 30, 2022 | 142,000.00 |
| Jun 30, 2022 | 205,000.00 |
| Mar 31, 2022 | 194,000.00 |
| Dec 31, 2021 | 312,000.00 |
| Sep 30, 2021 | 109,000.00 |
| Jun 30, 2021 | 515,000.00 |